Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice

Brain Research Bulletin

Volumn 95, Issue , 2013, Pages 61-69

  Cunha, Mauricio P ^a   Pazini, Francis L ^a   Oliveira, ágatha ^a   Machado, Daniele G ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant; Creatine; Serotonergic system; Tail suspension test

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTIDEPRESSANT AGENT; CITALOPRAM; CREATINE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; SEROTONIN 1A RECEPTOR; SERTRALINE;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CREATINE; DEPRESSION; DEPRESSIVE DISORDER; HINDLIMB SUSPENSION; HUMANS; MICE; PAROXETINE; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS;

EID: 84878106976     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.01.005     Document Type: Article

References (65)

1. 1A receptor: implications for mental illness. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 2012, 367:2402-2415.
2. Allen P.J., D'Anci K.E., Kanarek R.B., Renshaw P.F. Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner. Neuropsychopharmacology 2010, 35:534-546.
3. Allen P.J., D'Anci K.E., Kanarek R.B., Renshaw P.F. Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. Pharmacology Biochemistry and Behavior 2012, 101:588-601.
4. Amital D., Vishne T., Rubinow A., Levine J. Observed effects of creatine monohydrate in a patient with depression and fibromyalgia. American Journal of Psychiatry 2006, 163:1840-1841.
5. Andres R.H., Ducray A.D., Schlattner U., Wallimann T., Widmer H.R. Functions and effects of creatine in the central nervous system. Brain Research Bulletin 2008, 76:329-343.
6. Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry 1994, 51:248-251.
7. 1A antagonists. Trends in Neurosciences 1996, 19:378-383.
8. Assié M.B., Koek W. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. British Journal of Pharmacology 1996, 119:845-850.
9. Assis L.C., Rezin G.T., Comim C.M., Valvassori S.S., Jeremias I.C., Zugno A.I., Quevedo J., Streck E.L. Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Revista Brasileira de Psiquiatria 2009, 31:247-252.
10. 1A receptor agonist on striatal dopamine release. Synapse 2005, 57:67-75.
11. Bessman S.P., Carpenter C.L. The creatine-creatine phosphate energy shuttle. Annual Review of Biochemistry 1985, 54:831-862.
12. Brocardo P.S., Budni J., Kaster M.P., Santos A.R., Rodrigues A.L. Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Neuropharmacology 2008, 54:464-473.
13. Cascade E., Kalali A.H., Kennedy S.H. Real-world data on SSRI antidepressant side effects. Psychiatry 2009, 6:16-18.
14. Cesana R., Ceci A., Ciprandi C., Borsini F. Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice. Journal of Pharmacy and Pharmacology 1993, 45:473-475.
15. 4 receptor agonist. Psychopharmacology 2006, 188:244-251.
16. 2A receptors. International Immunology 2003, 15:233-240.
17. Cunha M.P., Machado D.G., Bettio L.E.B., Capra J.C., Rodrigues A.L.S. Interaction of zinc with antidepressants in the tail suspension test. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1913-1920.
18. Cunha M.P., Machado D.G., Capra J.C., Jacinto J., Bettio L.E., Rodrigues A.L.S. Antidepressant-like effect of creatine in mice involves dopaminergic activation. Journal of Psychopharmacology 2012, 26:1489-1501. 10.1177/0269881112447989.
19. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 2004, 61:450-458.
20. Di Cesare Mannelli L., Vivoli E., Salvicchi A., Schiavone N., Koverech A., Messano M., Nicolai R., Benatti P., Bartolini A., Ghelardini C. Antidepressant-like effect of artemin in mice: a mechanism for acetyl-l-carnitine activity on depression. Psychopharmacology 2011, 218:347-356. 10.1007/s00213-011-2326-0.
21. 1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. Journal of Neuroscience 2005, 25:10831-10843.
22. Dremencov E., Gispan-Herman I., Rosenstein M., Mendelman A., Overstreet D.H., Zohar J., Yadid G. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28:141-147.
23. Elhwuegi A.S. Central monoamines and their role in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28:435-451.
24. 1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 2002, 26:565-573.
25. Herring N.R., Schaefer T.L., Tang P.H., Skelton M.R., Lucot J.P., Gudelsky G.A., Vorhees C.V., Williams M.T. Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neuroscience 2008, 9:49.
26. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Research Bulletin 2005, 67:53-61.
27. Kato T., Takahashi S., Shioiri T., Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Affective Disorders 1992, 26:223-230.
28. Kim S.Y., Lee Y.J., Kim H., Lee D.W., Woo D.C., Choi C.B., Chae J.H., Choe B.Y. Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo(1)H-MRS study at 9.4T. Brain Research 2010, 1348:105-113.
29. Knox D., Perrine S.A., George S.A., Galloway M.P., Liberzon I. Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex. Neuroscience Letters 2010, 480:16-20.
30. Kondo D.G., Sung Y.H., Hellem T.L., Fiedler K.K., Shi X., Jeong E.K., Renshaw P.F. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study. Journal of Affective Disorders 2011, 135:354-361.
31. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 2000, 22:191-199.
32. Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drugs. Journal of Clinical Psychiatry 1991, 52:24-31.
33. Lugenbiel P., Sartorius A., Vollmayr B., Schloss P. Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness. World Journal of Biological Psychiatry 2010, 11:329-333.
34. 1A receptors. British Journal of Pharmacology 1993, 108:669-677.
35. Lyoo I.K., Yoon S., Kim T.S., Hwang J., Kim J.E., Won W., Bae S., Renshaw P.F. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. American Journal of Psychiatry 2012, 169:937-945. 10.1176/appi.ajp.2012.12010009.
36. Machado D.G., Bettio L.E., Cunha M.P., Capra J.C., Dalmarco J.B., Pizzolatti M.G., Rodrigues A.L. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:642-650.
37. Maes M., Berk M., Goehler L., Song C., Anderson G., Gałecki P., Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Medicine 2012, 10:66.
38. Middlemiss D.N., Price G.W., Watson J.M. Serotonergic targets in depression. Current Opinion in Pharmacology 2002, 2:18-22.
39. Millan M.J. The role of monoamines in the actions of established and " novel" antidepressant agents: a critical review. European Journal of Pharmacology 2004, 500:371-384.
40. Mogha A., Guariglia S.R., Debata P.R., Wen G.Y., Banerjee P. Serotonin 1A receptor-mediated signaling through ERK and PKCα is essential for normal synaptogenesis in neonatal mouse hippocampus. Translational Psychiatry 2012, 2:e66.
41. Nelson J.C. Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies. CNS Spectrums 2007, 12:6-9.
42. O'Leary O.F., Bechtholt A.J., Crowley J.J., Hill T.E., Page M.E., Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 2007, 192:357-371.
43. 1B receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 2001, 24:391-398.
44. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 1999, 147:162-167.
45. Papakostas G.I. Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder. Journal of Clinical Psychiatry 2009, 70:18-22.
46. Papakostas G.I., Alpert J.E., Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Current Psychiatry Reports 2003, 5:460-466.
47. 11C]raclopride. International Journal of Neuropsychopharmacology 2004, 7:431-439.
48. Pulvirenti G., Valerio C., Spadaro F., D'Agata V., Freni V., Nardo L., Drago F. Acetylcarnitine reduces the immobility of rats in a despair test (constrained swim). Behavioral and Neural Biology 1990, 54:110-114.
49. 1B receptors in antidepressant drug actions in the mouse forced swimming test. European Journal of Pharmacology 1996, 318:213-220.
50. Reus G.Z., Stringari R.B., Goncalves C.L., Scaini G., Carvalho-Silva M., Jeremias G.C., Jeremias I.C., Ferreira G.K., Streck E.L., Hallak J.E., Zuardi A.W., Crippa J.A., Quevedo J. Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain. Depression Research and Treatment 2012, 987397.
51. Reus G.Z., Stringari R.B., Rezin G.T., Fraga D.B., Daufenbach J.F., Scaini G., Benedet J., Rochi N., Streck E.L., Quevedo J. Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain. Journal of Neural Transmission 2012, 119:481-491.
52. Rodrigues A.L.S., da Silva G.L., Mateussi A.S., Fernandes E.S., Miguel O.G., Yunes R.A., Calixto J.B., Santos A.R.S. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sciences 2002, 70:1347-1358.
53. 1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters 1996, 219:123-126.
54. Santos P.M., Scaini G., Rezin G.T., Benedet J., Rochi N., Jeremias G.C., Carvalho-Silva M., Quevedo J., Streck E.L. Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Research Bulletin 2009, 80:327-330.
55. Silveri M.M., Parow A.M., Villafuerte R.A., Damico K.E., Goren J., Stoll A.L., Cohen B.M., Renshaw P.F. S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biological Psychiatry 2003, 54:833-839.
56. Smeland O.B., Meisingset T.W., Borges K., Sonnewald U. Chronic acetyl-l-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice. Neurochemistry International 2012, 61:100-107.
57. 7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology 2004, 46:52-62.
58. Stahl S.M. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. Journal of Affective Disorders 1998, 51:215-235.
59. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
60. 1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Polish Journal of Pharmacology 2002, 54:615-623.
61. Wong M.L., Licinio J. Research and treatment approaches to depression. Nature Reviews Neuroscience 2001, 2:343-351.
62. Wyss M., Smeitink J., Wevers R.A., Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochimica et Biophysica Acta 1992, 1102:119-166.
63. Yadid G., Pacak K., Kopin I.J., Goldstein D.S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. Journal of Pharmacology and Experimental Therapeutics 1994, 270:1158-1165.
64. 1B/1D receptors in human interferon-alpha-induced immobility in the mouse forced swimming test. Arzneimittel-Forschung 2010, 60:109-115.
65. Zomkowski A.D.E., Rosa A.O., Lin J., Santos A.R., Calixto J.B., Rodrigues A.L.S. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Research 2004, 1023:253-263.